Methocarbamol
Methocarbamol, Robaxin, Robaxisal (methocarbamol) is a small molecule pharmaceutical. Methocarbamol was first approved as Robaxisal on 1982-01-01. It is used to treat muscle cramp, muscle rigidity, myositis, pain, and spasm amongst others in the USA. It is known to target carbonic anhydrase 1.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Trade Name
FDA
EMA
Methocarbamol, Robaxin (discontinued: Delaxin, Forbaxin, Methocarbamol, Robaxin)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Methocarbamol
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ROBAXIN | Hikma Pharmaceuticals | N-011790 RX | 1982-01-01 | 1 products, RLD, RS |
Show 2 discontinued
Aspirin
+
Methocarbamol
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ROBAXISAL | A.H. Robins Company | N-012281 DISCN | 1982-01-01 | 1 products, RLD |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| methocarb 500-ezs | unapproved drug other | 2020-11-10 |
| methocarbamol | ANDA | 2024-10-24 |
| methocarbamol and aspirin | ANDA | 2021-03-11 |
| methocarbamol methocarbamol | ANDA | 2024-01-31 |
| methocarbamol tablets, usp, 500 mg methocarbamol tablets, usp, 750 mg | ANDA | 2024-10-08 |
| robaxin | New Drug Application | 2024-04-10 |
| tanlor | ANDA | 2024-07-22 |
Indications
FDA
EMA
Show 2 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
M: Musculo-skeletal system drugs
— M03: Muscle relaxants
— M03B: Muscle relaxants, centrally acting agents
— M03BA: Carbamic acid esters, centrally acting muscle relaxants
— M03BA03: Methocarbamol
— M03BA53: Methocarbamol, combinations excl. psycholeptics
— M03BA73: Methocarbamol, combinations with psycholeptics
HCPCS
Code | Description |
|---|---|
| J2800 | Injection, methocarbamol, up to 10 ml |
Clinical
Clinical Trials
37 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Postoperative pain | D010149 | — | G89.18 | — | — | 1 | 3 | 1 | 5 |
| Low back pain | D017116 | HP_0003419 | M54.5 | — | — | 1 | 2 | 1 | 4 |
| Back pain | D001416 | HP_0003418 | M54 | — | — | 1 | 2 | 1 | 4 |
| Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | — | 2 | 1 | 3 |
| Wounds and injuries | D014947 | — | T14.8 | — | — | — | 1 | 1 | 2 |
| Acute pain | D059787 | — | R52 | — | — | — | 1 | 1 | 2 |
| Rib fractures | D012253 | — | — | — | — | — | 1 | 1 | 2 |
| Opioid-related disorders | D009293 | EFO_0005611 | F11 | — | — | — | 1 | — | 1 |
| Chronic pain | D059350 | HP_0012532 | — | — | — | — | 1 | — | 1 |
| Morphine dependence | D009021 | EFO_0005612 | — | — | — | — | 1 | — | 1 |
Show 9 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Heart failure | D006333 | HP_0001635 | I50 | 1 | 5 | 1 | — | — | 6 |
| Sclerosis | D012598 | — | — | — | 1 | 1 | — | 1 | 3 |
| Systemic scleroderma | D012595 | EFO_0000717 | M34.0 | — | 1 | 1 | — | — | 2 |
| Diffuse scleroderma | D045743 | EFO_0000404 | — | — | 1 | 1 | — | — | 2 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | 1 | — | — | 1 |
| Muscle cramp | D009120 | HP_0003394 | — | — | — | 1 | — | — | 1 |
| Spasm | D013035 | — | M62.83 | — | — | 1 | — | — | 1 |
| Pain | D010146 | EFO_0003843 | R52 | — | — | 1 | — | — | 1 |
| Anterior cruciate ligament injuries | D000070598 | — | — | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular diseases | D002318 | HP_0001626 | — | — | 1 | — | — | — | 1 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 1 | — | — | — | 1 |
| Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | — | 1 | — | — | — | 1 |
| Coronary disease | D003327 | — | — | — | 1 | — | — | — | 1 |
| Coronary artery disease | D003324 | — | I25.1 | — | 1 | — | — | — | 1 |
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | 1 | — | — | — | 1 |
| Induced labor | D007751 | — | — | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pre-eclampsia | D011225 | EFO_0000668 | O14 | 1 | — | — | — | — | 1 |
| Eclampsia | D004461 | HP_0100601 | O15 | 1 | — | — | — | — | 1 |
| Renal insufficiency | D051437 | HP_0000083 | N19 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Assisted reproductive techniques | D027724 | — | — | — | — | — | — | 1 | 1 |
| Infertility | D007246 | HP_0000789 | — | — | — | — | — | 1 | 1 |
| Oogenesis | D009866 | — | — | — | — | — | — | 1 | 1 |
| Multiple fractures | D000069076 | HP_0002757 | — | — | — | — | — | 1 | 1 |
| Multiple trauma | D009104 | — | T07 | — | — | — | — | 1 | 1 |
| Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | — | — | — | 1 | 1 |
| Relapsing-remitting multiple sclerosis | D020529 | EFO_0003929 | — | — | — | — | — | 1 | 1 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | — | — | 1 | 1 |
| Nephrolithiasis | D053040 | — | N20.0 | — | — | — | — | 1 | 1 |
| Kidney calculi | D007669 | EFO_0004253 | N20 | — | — | — | — | 1 | 1 |
Show 12 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Methocarbamol |
| INN | methocarbamol |
| Description | 2-hydroxy-3-(2-methoxyphenoxy)propyl carbamate is a carbamate ester that is glycerol in which one of the primary alcohol groups has been converted to its 2-methoxyphenyl ether while the other has been converted to the corresponding carbamate ester. It is a carbamate ester, a secondary alcohol and an aromatic ether. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | COc1ccccc1OCC(O)COC(N)=O |
Identifiers
| PDB | — |
| CAS-ID | 108914-10-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1201117 |
| ChEBI ID | 77498 |
| PubChem CID | 4107 |
| DrugBank | DB00423 |
| UNII ID | 125OD7737X (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
CA1
CA1
Organism
Homo sapiens
Gene name
CA1
Gene synonyms
NCBI Gene ID
Protein name
carbonic anhydrase 1
Protein synonyms
CA-I, CAB, Carbonate dehydratase I, Carbonic anhydrase B, Carbonic anhydrase I, Cyanamide hydratase CA1, epididymis secretory protein Li 11, epididymis secretory sperm binding protein
Uniprot ID
Mouse ortholog
Car1 (12346)
carbonic anhydrase 1 (Q9DC84)
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Methocarbamol
+
Aspirin
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Methocarbamol
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 928 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
2,469 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use